The largest database of trusted experimental protocols

Cd28 37.51

Manufactured by BioXCell

The CD28 (37.51) is a laboratory equipment used for cell culture research. It serves as a co-stimulatory receptor, which plays a crucial role in T-cell activation and proliferation.

Automatically generated - may contain errors

2 protocols using cd28 37.51

1

MSCV-based Retroviral Vector Targeting CD4

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two MSCV-based γ retroviral vectors were used to target the Cd4 gene as described by Kotov et al. 29 . One vector encoded Cas9 and the fluorescent protein mNeongreen and the other either Cd4 or control LacZ guide RNAs (gRNAs) and the fluorescent protein mAmetrine 30 . Both vectors were produced by modifying the LMP-Amt vector from S. Crotty (La Jolla Institute) as described by Kotov et al. 29 . Platinum-E cells (Cell Biolabs) were grown in complete DMEM (Life Technologies) and transfected with the aforementioned plasmids. Virus-containing supernatants were harvested several days later. B3K508 T cells were cultured with complete IMDM (MilliporeSigma) containing IL-7 (Tonbo Biosciences) and then activated in plates coated with CD3 (2C11; Bio X Cell) and CD28 (37.51; Bio X Cell) antibodies. The cells were transduced with retroviral supernatant and polybrene (MilliporeSigma) 24 and 40 hours after activation and transferred to uncoated plates without CD3 or CD28 Abs for five days, the last three in complete IMDM-containing IL-7 (Tonbo Biosciences). The cells were then stained with P5R:I-Ab or P5R:I-Ab-4E tetramers and then BV786-labeled CD4 (RM4–5; BD Biosciences) antibody and a fixable viability dye (Ghost Dye Red 780; Tonbo Biosciences). The stained cells were analyzed by flow cytometry as described below.
+ Open protocol
+ Expand
2

CD4+ T Cell Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocytes were isolated from peripheral lymph nodes and spleen of age- and sex- matched mice and purified with CD4 microbeads (L3T4, Miltenyi Biotec). Purified CD4+ T cells were cultured in RPMI 1640 medium containing 10% FBS, 1% penicillin-streptomycin and 75 μM of β-Mercaptoethanol and activated with plate-coated 2.5 μg/ml CD3 (145-2c11, Bio-X-Cell) and 1 μg/ml CD28 (37.51, Bio-X-Cell) antibodies. For Treg differentiation, designated doses of TGF-β (0.01–2 ng/ml) and IL-2 (20 U/ml) were added into culture medium. CCT251921 (HY-19984, MedChem Express) and Senexin A (487510, Tocris Bioscience) were used to block Cdk8/Cdk19 activity. TGF-β receptor I (Alk5) inhibitor SB431542 (S1067, Selleckchem) was used to block TGF-β signaling. For proliferation assay, 2 μM of CFSE (C1157, Life Technologies) was used to label CD4+ T cells before differentiation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!